Duni Ab · OMXSTO:DUNI

Duni Ab — Q2 2008 Earnings Presentation

18 slides from Duni Ab's earnings presentation, 2008

  1. Slide 1: Q2 2008 Presentation

    Q2 2008 Presentation www.duni.com 1

  2. Slide 2: Disclaimer

    Disclaimer  This presentation has been prepared by Duni AB (the “Company”) solely for use at this investor presentation and is furnished to you solely for your information and may not be reproduced or redistributed, in whole or in part, to any other person. By attending the meeting where this prese

  3. Slide 3: Contents

    Contents  2008 Q2 highlights  Business areas  Financials 3

  4. Slide 4: 2008 Q2 Highlights

    2008 Q2 Highlights • Net sales increased with 4.2% to SEK 1012 m • Operating profit amounted to SEK 90 m (73) • Operating margin amounted to 8.9% (8.5%) • Solid growth in Professional and improved margins - Good development in Central Europe - Strong growth in Duni FoodSolutions • Continued improvem

  5. Slide 5: Share Price Development

    Share Price Development Share price per 30/06/08 Ownership structure per 30/06/08 Name # of Shares % Mellby Gård Investerings AB 14 094 500 29,99% Duni Holding AB, EQT Partners AB 7 858 644 16,72% PolarisCapital Fund Ltd 4 222 200 8,98% SEB Investment Management 3 100 987 6,60% Cominvest 2 431 200 5

  6. Slide 6: Duni – the European Market Leader for Table Top Solutions

    Duni – the European Market Leader for Table Top Solutions Duni Duni Key Key financials financials Table Top Full year 2007 Tissue 14% ∙ Sales: SEK 4.0 billion (+5.9%) Professional Retail 66% 20% ∙ EBIT: SEK 394 million (277) ∙ EBIT margin: 9.9% (8.7%) ¹ Manufactured Q2 2008 Napkins Plates Table cove

  7. Slide 7: 2008 Market Outlook

    2008 Market Outlook HORECA market growing in line or slightly above GDP • Positive eating out trend • Continued strong growth in take-away sector Retail growth in line with GDP • Private label stagnating Higher uncertainty • GDP forecasts revised downward since Q1 Raw material prices and costs of ce

  8. Slide 8: Business Areas

    AVR ane LSBVEPPPEL ENS

  9. Slide 9: Professional – Stable Development

    Professional – Stable Development Sales Sales and EBIT 11 and EBIT Geographical Geographical split split –– sales sales Q2 Q2 2008 2008 MSEK 3,000 14% Net Sales - Professional Q2 2008 Q2 2007 Growth 12% 2,500 Nordic region 176 168 4,8% 10% Central Europe 402 378 6,3% 2,000 Southern & Eastern Europe

  10. Slide 10: Retail – Turnaround

    Retail – Turnaround Sales Sales and EBIT 11 and EBIT Geographical Geographical split split –– sales sales Q2 Q2 2008 2008 MSEK 900 -+6% Net Sales - Retail Q2 2008 Q2 2007 Growth -+4% 850 Nordic region 40 36 11,1% +2% 800 Central Europe 122 126 -3,2% Southern & Eastern Europe 2 1 100,0% -0% Rest of t

  11. Slide 11: Tissue

    Tissue Sales Sales and EBIT 11 and EBIT Sales Sales mix mix Q2 Q2 2008 2008 MSEK 650 14% 12% 600 Internal 10% 47% 550 External 53% 8% 500 6% 450 4% 400 2% Tissue Tissue in-house in-house provides provides competitive competitive 350 0% advantage advantage 2005 2006 2007 LTM Sales EBIT margin Healthy

  12. Slide 12: Financials

    Financials 12

  13. Slide 13: Momentum in Top-Line Growth

    Momentum in Top-Line Growth LTM LTM Sales Sales Sales Sales growth growth MSEK MSEK 2006 2007 Q2 2007 Q2 2008 4 100 1 150 4 050 1 100 Professional 5.7% 6.3% 5.6% 6.2% 1 050 4 000 Retail -6.2% 4.2% 1.2% 0.6% 1 000 3 950 950 Tissue 4.5% 6.9% 13.5% 0.0% 3 900 900 Total 2.9% 5.9% 5.9% 4.2% 3 850 850 Q4

  14. Slide 14: Margin Expansion

    Margin Expansion Operating Operating profit profit (MSEK) (MSEK) Operating Operating margin margin MSEK 2006 2007 Q2 2007 Q2 2008 400 10% 9% 350 Professional 11.7% 12.9% 11.6% 12.7% 8% 300 -7% Retail -0.9% 0.6% -8.0% -5.0% 250 6% 200 5% Tissue 8.5% 8.9% 6.3% 6.2% 4% 150 3% Non- 100 recurring -1.3% 0

  15. Slide 15: Income Statement

    Income Statement 2005 2006 2007 LTM Net sales 3,656 3,762 3,985 4,072 Cost of goods sold -2,829 -2,812 -2,948 -2,982 Gross profit 827 950 1,037 1,090 Gross margin 22.6% 25.3% 26.0% 26.8% Selling expenses -510 -459 -446 -462 Adminstrative expenses -185 -219 -208 -211 Research and development expenses

  16. Slide 16: Balance Sheet

    Balance Sheet (SEK in millions) 30/06/2008 30/06/2008 Intangible assets 1,228 Shareholders’ equity 1,414 Tangible assets 452 Interest bearing debt 1,094 Financial fixed assets 372 Pension liabilities 201 Inventory 556 Other long term liabilities 22 Accounts receivable 548 Accounts payable 304 Other

  17. Slide 17: Simplified Cash Flow Profile

    Simplified Cash Flow Profile (SEK million) 2006 2007 H1 2007 H2 2008 Operating profit 277 393 151 176 Depreciation 82 89 43 50 Change in operating working capital1) -32 20 -127 -58 Inventory 26 -24 -35 -55 Accounts receivable 8 14 -76 -2 Accounts payable -66 30 -16 -1 Other operating working capital

  18. Slide 18: Financial Targets

    Financial Targets LTM ∙ Organic growth of 5% over a business cycle 4.7% Sales Sales growth growth >> 5% 5% ∙ Consider acquisitions to reach new markets or to - strengthen current market positions ∙ Top-line growth EBIT 10.3% EBIT margin margin >> 10% 10% ∙ Improvements in manufacturing and sourcing

Duni — Q2 2008 Earnings Presentation on 6ix